Daxor Net Income 2010-2011 | DXR

Daxor net income from 2010 to 2011. Net income can be defined as company's net profit or loss after all revenues, income items, and expenses have been accounted for.
Daxor Annual Net Income
(Millions of US $)
2011 $-7
2010 $5
2009 $6
Daxor Quarterly Net Income
(Millions of US $)
2011-12-31 $-1
2011-09-30 $-4
2011-06-30 $-0
2011-03-31 $-1
2010-12-31 $2
2010-09-30 $3
2010-06-30 $0
2010-03-31 $-0
2009-12-31 $-1
2009-09-30 $3
2009-06-30 $6
2009-03-31 $-2
Sector Industry Market Cap Revenue
Medical Medical - Outpatient & Home Care $0.035B $0.000B
Daxor Corporation is a medical device manufacturing corporation with additional biotech services.
Stock Name Country Market Cap PE Ratio
Fresenius SE (FSNUY) Germany $21.893B 0.00
Quest Diagnostics (DGX) United States $18.837B 18.92
DaVita (DVA) United States $12.594B 16.06
Encompass Health (EHC) United States $10.162B 22.77
Chemed (CHE) United States $8.332B 25.60
Elanco Animal Health (ELAN) United States $5.561B 13.23
Option Care Health (OPCH) United States $5.354B 25.37
RadNet (RDNT) United States $4.540B 100.54
LifeStance Health (LFST) United States $3.050B 0.00
Amedisys (AMED) United States $3.033B 21.58
Astrana Health (ASTH) United States $2.192B 29.97
Addus HomeCare (ADUS) United States $2.053B 24.09
U.S Physical Therapy (USPH) United States $1.314B 34.53
Pennant (PNTG) United States $0.891B 36.01
Aveanna Healthcare Holdings (AVAH) United States $0.889B 0.00
Atai Life Sciences (ATAI) Germany $0.386B 0.00
Bioqual (BIOQ) United States $0.054B 0.00
Ontrak (OTRK) United States $0.007B 0.00
MEDIROM Healthcare Technologies (MRM) Japan $0.004B 0.00
IMAC Holdings (BACK) United States $0.001B 0.00
Psychemedics (PMD) United States $0.000B 0.00